Correction to: Cell Death and Disease (2017) 8 (9):e3048. doi: 10.1038/cddis.2017.438; published online 14 September 2017 Since the publication of this paper, the authors have noted that there was an error in Figure 1d, in that, the GAPDH for combination treatment with CA-4 and CQ in SJSA cells by mistake duplicated for CQ alone treatment (Figure 3e).
Similar content being viewed by others
Correction to: Cell Death and Disease (2017) 8 (9):e3048. doi: 10.1038/cddis.2017.438; published online 14 September 2017
Since the publication of this paper, the authors have noted that there was an error in Figure 1d, in that, the GAPDH for combination treatment with CA-4 and CQ in SJSA cells by mistake duplicated for CQ alone treatment (Figure 3e). This error has now been rectified. The correct figure is shown below.
The authors would like to apologize for any inconvenience this may have caused.
Additional information
The online version of the original article can be found at 10.1038/cddis.2017.438
Rights and permissions
Cell Death and Disease is an open-access journal published by Nature Publishing Group. This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
About this article
Cite this article
Wang, H., Li, W., Xu, J. et al. Corrigendum: NDRG1 inhibition sensitizes osteosarcoma cells to combretastatin A-4 through targeting autophagy. Cell Death Dis 8, e3131 (2017). https://doi.org/10.1038/cddis.2017.558
Published:
Issue Date:
DOI: https://doi.org/10.1038/cddis.2017.558